QNRX vs. CLSE
QNRX (Quoin Pharmaceuticals Ltd DRC) is a stock, while CLSE (Convergence Long/Short Equity ETF) is Long-Short fund actively managed by Convergence. Over the past 3 years, QNRX returned -74.72%/yr vs 29.42%/yr for CLSE. Their 0.06 correlation means their historical movements had little consistent relationship.
Performance
QNRX vs. CLSE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, QNRX achieves a -69.16% return, which is significantly lower than CLSE's 24.37% return.
QNRX
- 1D
- 1.14%
- 1M
- -2.84%
- 6M
- -38.32%
- YTD
- -69.16%
- 1Y
- -34.75%
- 3Y*
- -74.72%
- 5Y*
- -86.22%
- 10Y*
- -68.96%
- ALL TIME*
- -69.12%
CLSE
- 1D
- 0.24%
- 1M
- 2.19%
- 6M
- 20.32%
- YTD
- 24.37%
- 1Y
- 44.25%
- 3Y*
- 29.42%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 20.44%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $15.17M | $11.74M | $9.80M | |
| $48.80K | $101.62K | $922.04K |
QNRX vs. CLSE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
QNRX Quoin Pharmaceuticals Ltd DRC | -69.16% | -36.64% | -86.73% | -71.21% | -91.59% |
CLSE Convergence Long/Short Equity ETF | 24.37% | 20.44% | 35.54% | 17.54% | -4.38% |
Correlation
The correlation between QNRX and CLSE is -0.08, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.08 |
Correlation (3Y) Balances recent behavior with more history. | 0.00 |
Correlation (All Time) Calculated using the full available price history since Feb 22, 2022 | 0.06 |
The correlation between QNRX and CLSE shifts across timeframes, from -0.08 (1 year) to 0.06 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
QNRX vs. CLSE — Risk / Return Rank
QNRX
CLSE
QNRX vs. CLSE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Quoin Pharmaceuticals Ltd DRC (QNRX) and Convergence Long/Short Equity ETF (CLSE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| QNRX | CLSE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.27 | ||
| Sortino ratioReturn per unit of downside risk | -3.16 | ||
| Omega ratioGain probability vs. loss probability | 1.14 | 1.53 | -0.39 |
| Calmar ratioReturn relative to maximum drawdown | -0.39 | 8.77 | -9.17 |
| Martin ratioReturn relative to average drawdown | -0.60 | 29.59 | -30.19 |
Loading charts...
Drawdowns
QNRX vs. CLSE - Drawdown Comparison
The maximum QNRX drawdown since its inception was -100.00%, which is greater than CLSE's maximum drawdown of -16.45%. Use the drawdown chart below to compare losses from any high point for QNRX and CLSE.
Loading charts...
Drawdown Indicators
| QNRX | CLSE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -16.45% | -83.55% |
Max Drawdown (1Y)Largest decline over 1 year | -85.43% | -4.85% | -80.58% |
Max Drawdown (3Y)Largest decline over 3 years | -98.76% | -16.45% | -82.31% |
Max Drawdown (5Y)Largest decline over 5 years | -100.00% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -100.00% | — | — |
Current DrawdownCurrent decline from peak | -100.00% | -1.34% | -98.66% |
Average DrawdownAverage peak-to-trough decline | -81.73% | -3.52% | -78.21% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 56.21% | 1.44% | +54.77% |
Volatility
QNRX vs. CLSE - Volatility Comparison
Quoin Pharmaceuticals Ltd DRC (QNRX) has a higher volatility of 11.76% compared to Convergence Long/Short Equity ETF (CLSE) at 3.24%. This indicates that QNRX's price experiences larger fluctuations and is considered to be riskier than CLSE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| QNRX | CLSE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.76% | 3.24% | +8.52% |
Volatility (6M)Calculated over the trailing 6-month period | 69.20% | 10.80% | +58.40% |
Volatility (1Y)Calculated over the trailing 1-year period | 192.84% | 13.79% | +179.05% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 213.90% | 13.86% | +200.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 171.77% | 13.86% | +157.91% |
Dividends
QNRX vs. CLSE - Dividend Comparison
QNRX has not paid dividends to shareholders, while CLSE's dividend yield for the trailing twelve months is around 0.77%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
CLSE Convergence Long/Short Equity ETF | 0.77% | 0.95% | 0.93% | 1.21% | 0.85% |
QNRX Quoin Pharmaceuticals Ltd DRC | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
QNRX and CLSE have a correlation of -0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
QNRX has higher volatility (11.76%) compared to CLSE (3.24%). In terms of maximum drawdown, QNRX dropped -100.00% vs CLSE's -16.45%.
CLSE currently has the higher Sharpe Ratio (3.09 vs -0.18), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for QNRX and CLSE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer